Abstract
Background: Among the hypertension-related complications, the onset of intracerebral hemorrhage (ICH) is a destructive stage and is the most disabling type of stroke that has the highest death rate. At present, there is no promising treatment for ICH. Objectives: The present investigation was aimed at evaluating the safeguarding effect of scopoletin against ICH-induced brain injury. Methods: We used Wistar male rats and divided them into 4 groups. Group 1 served as control, group 2 was induced with ICH, group 3 served as scopoletin-pretreated ICH rats, and group 4 as scopoletin drug control. During the experimental period, neurobehavioral outcome, cerebral edema, and neuroinflammation parameters were evaluated using RT-PCR and other biochemical analyses. Results: The rats that received scopoletin treatment demonstrated a significant attenuation in neurological deficits, neurodegeneration markers expression (TREM-1, SERPINE-1), and restored cerebral edema compared to ICH animals. On the other hand, an upsurge in inflammatory cytokines, for example, TNF-α, IL-13, IL-1β, and IL-17, was observed in ICH rats and was reduced to the level near normalcy in the scopoletin-treated groups. Conclusion: Our investigations propose that the effectiveness of scopoletin in improving acute neurological function after ICH is promising, and this could be a lead molecule for the development of treatment plans in ICH treatment.
References
1.
Sussman
ES
, Connolly
ES
Jr. Hemorrhagic transformation: a review of the rate of hemorrhage in the major clinical trials of acute ischemic stroke
. Front Neurol
. 2013
Jun
;4
:69
.
[PubMed]
1664-22952.
Kanamaru
K
, Suzuki
H
, Taki
W
. Cerebral infarction after aneurysmal subarachnoid hemorrhage
. Acta Neurochir Suppl (Wien)
. 2016
;121
:167
–72
.
[PubMed]
0065-14193.
Singh
N
, Bansal
Y
, Bhandari
R
, Marwaha
L
, Singh
R
, Chopra
K
, et al Naringin reverses neurobehavioral and biochemical alterations in intracerebroventricular collagenase-induced intracerebral hemorrhage in rats
. Pharmacology
. 2017
;100
(3-4
):172
–87
.
[PubMed]
0031-70124.
Bonsack
F
, Alleyne
CH
Jr, Sukumari-Ramesh
S
. Resveratrol Attenuates Neurodegeneration and Improves Neurological Outcomes after Intracerebral Hemorrhage in Mice
. Front Cell Neurosci
. 2017
Aug
;11
:228
.
[PubMed]
1662-51025.
Matsushita
K
, Meng
W
, Wang
X
, Asahi
M
, Asahi
K
, Moskowitz
MA
, et al Evidence for apoptosis after intercerebral hemorrhage in rat striatum
. J Cereb Blood Flow Metab
. 2000
Feb
;20
(2
):396
–404
.
[PubMed]
0271-678X6.
Gong
C
, Boulis
N
, Qian
J
, Turner
DE
, Hoff
JT
, Keep
RF
. Intracerebral hemorrhage-induced neuronal death
. Neurosurgery
. 2001
Apr
;48
(4
):875
–82
.
[PubMed]
0148-396X7.
Smith
EE
, Gurol
ME
, Eng
JA
, Engel
CR
, Nguyen
TN
, Rosand
J
, et al White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage
. Neurology
. 2004
Nov
;63
(9
):1606
–12
.
[PubMed]
0028-38788.
Nagase
H
, Visse
R
, Murphy
G
. Structure and function of matrix metalloproteinases and TIMPs
. Cardiovasc Res
. 2006
Feb
;69
(3
):562
–73
.
[PubMed]
0008-63639.
Barr
TL
, Latour
LL
, Lee
KY
, Schaewe
TJ
, Luby
M
, Chang
GS
, et al Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9
. Stroke
. 2010
Mar
;41
(3
):e123
–8
.
[PubMed]
0039-249910.
Villapol
S
, Fau
S
, Renolleau
S
, Biran
V
, Charriaut-Marlangue
C
, Baud
O
. Melatonin promotes myelination by decreasing white matter inflammation after neonatal stroke
. Pediatr Res
. 2011
Jan
;69
(1
):51
–5
.
[PubMed]
0031-399811.
Shao
AW
, Wu
HJ
, Chen
S
, Ammar
AB
, Zhang
JM
, Hong
Y
. Resveratrol attenuates early brain injury after subarachnoid hemorrhage through inhibition of NF-κB-dependent inflammatory/MMP-9 pathway
. CNS Neurosci Ther
. 2014
Feb
;20
(2
):182
–5
.
[PubMed]
1755-593012.
Luo
C
, Xu
X
, Wei
X
, Feng
W
, Huang
H
, Liu
H
, et al Natural medicines for the treatment of fatigue: bioactive components, pharmacology, and mechanisms
. Pharmacol Res
. 2019
Oct
;148
:104409
.
[PubMed]
1043-661813.
Ding
Z
, Dai
Y
, Wang
Z
. Hypouricemic action of scopoletin arising from xanthine oxidase inhibition and uricosuric activity
. Planta Med
. 2005
Feb
;71
(2
):183
–5
.
[PubMed]
0032-094314.
Basu
M
, Mayana
K
, Xavier
S
, Balachandran
S
, Mishra
N
. Effect of scopoletin on monoamine oxidases and brain amines
. Neurochem Int
. 2016
Feb
;93
:113
–7
.
[PubMed]
0197-018615.
Shaw
CY
, Chen
CH
, Hsu
CC
, Chen
CC
, Tsai
YC
. Antioxidant properties of scopoletin isolated from Sinomonium acutum
. Phytother Res
. 2003
Aug
;17
(7
):823
–5
.
[PubMed]
0951-418X16.
Cai
X
, Yang
J
, Zhou
J
, Lu
W
, Hu
C
, Gu
Z
, et al Synthesis and biological evaluation of scopoletin derivatives
. Bioorg Med Chem
. 2013
Jan
;21
(1
):84
–92
.
[PubMed]
0968-089617.
Singh
N
, Bansal
Y
, Bhandari
R
, Marwaha
L
, Singh
R
, Chopra
K
, et al Resveratrol protects against ICV collagenase-induced neurobehavioral and biochemical deficits
. J Inflamm (Lond)
. 2017
Jun
;14
(1
):14
.
[PubMed]
1476-925518.
Xi
G
, Keep
RF
. Intracerebral hemorrhage: mechanisms and therapies
. Transl Stroke Res
. 2012
Jul
;3
(S1
Suppl 1
):1
–3
.
[PubMed]
1868-448319.
Hosaka
K
, Downes
DP
, Nowicki
KW
, Hoh
BL
. Modified murine intracranial aneurysm model: aneurysm formation and rupture by elastase and hypertension
. J Neurointerv Surg
. 2014
Jul
;6
(6
):474
–9
.
[PubMed]
1759-847820.
Ling
Y
, Wang
DD
, Sun
YX
, Zhao
DJ
, Ni
H
. Neuro-Behavioral Status and the Hippocampal Expression of Metabolic Associated Genes in Wild-Type Rat Following a Ketogenic Diet
. Front Neurol
. 2019
Feb
;10
:65
.
[PubMed]
1664-229521.
Qureshi
AI
, Ezzeddine
MA
, Nasar
A
, Suri
MF
, Kirmani
JF
, Hussein
HM
, et al Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States
. Am J Emerg Med
. 2007
Jan
;25
(1
):32
–8
.
[PubMed]
0735-675722.
Wallace
JD
, Levy
LL
. Blood pressure after stroke
. JAMA
. 1981
Nov
;246
(19
):2177
–80
.
[PubMed]
0098-748423.
Chu
S
, Sansing
L
. Evolution of blood pressure management in acute intracerebral hemorrhage
. F1000 Res
. 2017
Nov
;6
:2035
.
[PubMed]
2046-140224.
Wigati
D
, Anwar
K
, Sudarsono
, Nugroho
AE
. Hypotensive Activity of Ethanolic Extracts of Morinda citrifolia L. Leaves and Fruit in Dexamethasone-Induced Hypertensive Rat
. J Evid Based Complementary Altern Med
. 2017
Jan
;22
(1
):107
–13
.
[PubMed]
2156-587225.
Dastur
CK
, Yu
W
. Current management of spontaneous intracerebral haemorrhage
. Stroke Vasc Neurol
. 2017
Feb
;2
(1
):21
–9
.
[PubMed]
2059-869626.
Ghika-Schmid
F
, Ghika
J
, Regli
F
, Bogousslavsky
J
. Hyperkinetic movement disorders during and after acute stroke: the Lausanne Stroke Registry
. J Neurol Sci
. 1997
Mar
;146
(2
):109
–16
.
[PubMed]
0022-510X27.
Wahl
F
, Allix
M
, Plotkine
M
, Boulu
RG
. Neurological and behavioral outcomes of focal cerebral ischemia in rats
. Stroke
. 1992
Feb
;23
(2
):267
–72
.
[PubMed]
0039-249928.
Yao
X
, Ding
Z
, Xia
Y
, Wei
Z
, Luo
Y
, Feleder
C
, et al Inhibition of monosodium urate crystal-induced inflammation by scopoletin and underlying mechanisms
. Int Immunopharmacol
. 2012
Dec
;14
(4
):454
–62
.
[PubMed]
1567-576929.
Rothwell
N
, Allan
S
, Toulmond
S
. The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications
. J Clin Invest
. 1997
Dec
;100
(11
):2648
–52
.
[PubMed]
0021-973830.
Keep
RF
, Hua
Y
, Xi
G
. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets
. Lancet Neurol
. 2012
Aug
;11
(8
):720
–31
.
[PubMed]
1474-442231.
Zhou
W
, Liesz
A
, Bauer
H
, Sommer
C
, Lahrmann
B
, Valous
N
, et al Postischemic brain infiltration of leukocyte subpopulations differs among murine permanent and transient focal cerebral ischemia models
. Brain Pathol
. 2013
Jan
;23
(1
):34
–44
.
[PubMed]
1015-630532.
Barakat
W
, Safwet
N
, El-Maraghy
NN
, Zakaria
MN
. Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade
. Eur J Pharmacol
. 2014
Feb
;724
:43
–50
.
[PubMed]
0014-299933.
Yang
Y
, Zhang
Y
, Wang
Z
, Wang
S
, Gao
M
, Xu
R
, et al Attenuation of Acute Phase Injury in Rat Intracranial Hemorrhage by Cerebrolysin that Inhibits Brain Edema and Inflammatory Response
. Neurochem Res
. 2016
Apr
;41
(4
):748
–57
.
[PubMed]
0364-319034.
Norman
MU
, Hickey
MJ
. Mechanisms of lymphocyte migration in autoimmune disease
. Tissue Antigens
. 2005
Sep
;66
(3
):163
–72
.
[PubMed]
0001-281535.
Charo
IF
, Taubman
MB
. Chemokines in the pathogenesis of vascular disease
. Circ Res
. 2004
Oct
;95
(9
):858
–66
.
[PubMed]
0009-733036.
Garrood
T
, Lee
L
, Pitzalis
C
. Molecular mechanisms of cell recruitment to inflammatory sites: general and tissue-specific pathways
. Rheumatology (Oxford)
. 2006
Mar
;45
(3
):250
–60
.
[PubMed]
1462-032437.
Braunersreuther
V
, Mach
F
, Steffens
S
. The specific role of chemokines in atherosclerosis
. Thromb Haemost
. 2007
May
;97
(5
):714
–21
.
[PubMed]
0340-624538.
Naruko
T
, Ueda
M
, Haze
K
, van der Wal
AC
, van der Loos
CM
, Itoh
A
, et al Neutrophil infiltration of culprit lesions in acute coronary syndromes
. Circulation
. 2002
Dec
;106
(23
):2894
–900
.
[PubMed]
0009-732239.
Lei
B
, Dawson
HN
, Roulhac-Wilson
B
, Wang
H
, Laskowitz
DT
, James
ML
. Tumor necrosis factor α antagonism improves neurological recovery in murine intracerebral hemorrhage
. J Neuroinflammation
. 2013
Aug
;10
(1
):103
.
[PubMed]
1742-209440.
Kim
HJ
, Jang
SI
, Kim
YJ
, Chung
HT
, Yun
YG
, Kang
TH
, et al Scopoletin suppresses pro-inflammatory cytokines and PGE2 from LPS-stimulated cell line, RAW 264.7 cells
. Fitoterapia
. 2004
Jun
;75
(3-4
):261
–6
.
[PubMed]
0367-326X41.
Paul
AT
, Gohil
VM
, Bhutani
KK
. Modulating TNF-α signaling with natural products
. Drug Discov Today
. 2006
Aug
;11
(15-16
):725
–32
.
[PubMed]
1359-644642.
Bleharski
JR
, Kiessler
V
, Buonsanti
C
, Sieling
PA
, Stenger
S
, Colonna
M
, et al A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response
. J Immunol
. 2003
Apr
;170
(7
):3812
–8
.
[PubMed]
0022-176743.
Bouchon
A
, Facchetti
F
, Weigand
MA
, Colonna
M
. TREM-1 amplifies inflammation and is a crucial mediator of septic shock
. Nature
. 2001
Apr
;410
(6832
):1103
–7
.
[PubMed]
0028-083644.
Roy
A
, Coum
A
, Marinescu
VD
, Põlajeva
J
, Smits
A
, Nelander
S
, et al Glioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells
. Oncotarget
. 2015
Sep
;6
(27
):23647
–61
.
[PubMed]
1949-255345.
Min
H
, Hong
J
, Cho
IH
, Jang
YH
, Lee
H
, Kim
D
, et al TLR2-induced astrocyte MMP9 activation compromises the blood brain barrier and exacerbates intracerebral hemorrhage in animal models
. Mol Brain
. 2015
Apr
;8
(1
):23
.
[PubMed]
1756-660646.
Carmichael
ST
, Vespa
PM
, Saver
JL
, Coppola
G
, Geschwind
DH
, Starkman
S
, et al Genomic profiles of damage and protection in human intracerebral hemorrhage
. J Cereb Blood Flow Metab
. 2008
Nov
;28
(11
):1860
–75
.
[PubMed]
0271-678X47.
Semple
BD
, Kossmann
T
, Morganti-Kossmann
MC
. Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks
. J Cereb Blood Flow Metab
. 2010
Mar
;30
(3
):459
–73
.
[PubMed]
0271-678X© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
